Inflammatory bowel diseases (IBDs) such as Crohn’s disease and ulcerative colitis are chronic disorders of the digestive system. Gut health testing can help uncover genetic risks for these diseases by analyzing associated genes such as NOD2, allowing doctors to provide earlier, more personalized care for patients.
